{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:10:25Z","timestamp":1781277025857,"version":"3.54.1"},"reference-count":41,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/ijo.2016.3618","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T10:46:42Z","timestamp":1467888402000},"page":"913-933","source":"Crossref","is-referenced-by-count":21,"title":["Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients"],"prefix":"10.3892","volume":"49","author":[{"given":"Ayodele A.","family":"Alaiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakia","family":"Shinwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almohareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Malhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazzaa","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Owaidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said Y.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghuzayel","family":"Aldawsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Hanbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"key20180107185829_b1-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"key20180107185829_b2-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"key20180107185829_b3-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia--advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107185829_b4-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0889-8588(18)30494-5","article-title":"Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia","volume":"4","author":"Kantarjian","year":"1990","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107185829_b5-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V78.1.205.205","article-title":"Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): Comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"78","author":"Martiat","year":"1991","journal-title":"Blood"},{"key":"key20180107185829_b6-ijo-49-03-0913","first-page":"63","article-title":"Pathogenesis and progression of chronic myeloid leukemia","volume":"81","author":"Santucci","year":"1996","journal-title":"Haematologica"},{"key":"key20180107185829_b7-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.seminhematol.2010.07.001","article-title":"Chronic myeloid leukemia: A historical perspective","volume":"47","author":"Goldman","year":"2010","journal-title":"Semin Hematol"},{"key":"key20180107185829_b8-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1999.17.1.284","article-title":"Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine","volume":"17","author":"Kantarjian","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180107185829_b9-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"key20180107185829_b10-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/bcmd.1997.0155","article-title":"Inhibition of the ABL kinase activity blocks the proliferation of BCR\/ABL+ leukemic cells and induces apoptosis","volume":"23","author":"Gambacorti-Passerini","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"key20180107185829_b11-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2002-02-0545","article-title":"Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: High incidence of early complete and major cytogenetic responses","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"key20180107185829_b12-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood-2003-11-3800","article-title":"High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia","volume":"103","author":"Kantarjian","year":"2004","journal-title":"Blood"},{"key":"key20180107185829_b13-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/asheducation-2009.1.477","article-title":"Monitoring disease response to tyrosine kinase inhibitor therapy in CML","author":"Hughes","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180107185829_b14-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.10288","article-title":"Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles","volume":"98","author":"Alaiya","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107185829_b15-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<731::AID-IJC20>3.0.CO;2-A","article-title":"Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns","volume":"86","author":"Alaiya","year":"2000","journal-title":"Int J Cancer"},{"key":"key20180107185829_b16-ijo-49-03-0913","first-page":"39","article-title":"Proteomic analysis of soft tissue tumor implants treated with a novel polybisphosphonate","volume":"11","author":"Alaiya","year":"2014","journal-title":"Cancer Genomics Proteomics"},{"key":"key20180107185829_b17-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/1471-2407-14-830","article-title":"The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females","volume":"14","author":"Al-Moghrabi","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180107185829_b18-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/pmic.200800564","article-title":"Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures","volume":"9","author":"Li","year":"2009","journal-title":"Proteomics"},{"key":"key20180107185829_b19-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/sj.onc.1206620","article-title":"Chronic myelogenous leukemia molecular signature","volume":"22","author":"Nowicki","year":"2003","journal-title":"Oncogene"},{"key":"key20180107185829_b20-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/pr050149f","article-title":"Clinical cancer proteomics: Promises and pitfalls","volume":"4","author":"Alaiya","year":"2005","journal-title":"J Proteome Res"},{"key":"key20180107185829_b21-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1535-9476(20)33125-X","article-title":"Gel-based proteomics: What does MCP expect?","volume":"3","author":"Celis","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"key20180107185829_b22-ijo-49-03-0913","first-page":"55","article-title":"High-resolution two-dimensional gel electrophoresis and protein identification using western blotting and ECL detection","volume":"88","author":"Celis","year":"2000","journal-title":"EXS"},{"key":"key20180107185829_b23-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2","article-title":"Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors","volume":"73","author":"Alaiya","year":"1997","journal-title":"Int J Cancer"},{"key":"key20180107185829_b24-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/(SICI)1522-2683(19990101)20:4\/5<1039::AID-ELPS1039>3.0.CO;2-4","article-title":"Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity","volume":"20","author":"Alaiya","year":"1999","journal-title":"Electrophoresis"},{"key":"key20180107185829_b25-ijo-49-03-0913","first-page":"446","article-title":"Image analysis and diagnostic classification of hepatocellular carcinoma using neural networks and multivariate discriminant functions","volume":"71","author":"Erler","year":"1994","journal-title":"Lab Invest"},{"key":"key20180107185829_b26-ijo-49-03-0913","first-page":"295","article-title":"The contribution of image cytometry and artificial intelligence-related methods of numerical data analysis for adipose tumor histopathologic classification","volume":"75","author":"Goldschmidt","year":"1996","journal-title":"Lab Invest"},{"key":"key20180107185829_b27-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01811963","article-title":"A demonstration that breast cancer recurrence can be predicted by neural network analysis","volume":"21","author":"Ravdin","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107185829_b28-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-5347(01)62916-1","article-title":"Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks","volume":"160","author":"Tewari","year":"1998","journal-title":"J Urol"},{"key":"key20180107185829_b29-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-12-36","article-title":"Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation","volume":"12","author":"Albano","year":"2013","journal-title":"Mol Cancer"},{"key":"key20180107185829_b30-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3324\/haematol.13299","article-title":"Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling","volume":"94","author":"Verhaak","year":"2009","journal-title":"Haematologica"},{"key":"key20180107185829_b31-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/pr5002803","article-title":"Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia","volume":"13","author":"Alsagaby","year":"2014","journal-title":"J Proteome Res"},{"key":"key20180107185829_b32-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/pmic.201200066","article-title":"Label-free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: Disclosing new insights from therapy resistance","volume":"12","author":"Pizzatti","year":"2012","journal-title":"Proteomics"},{"key":"key20180107185829_b33-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/epr.12.55","article-title":"Investigation of therapy resistance mechanisms in myeloid leukemia by protein profiling of bone marrow extracellular fluid","volume":"9","author":"Gjertsen","year":"2012","journal-title":"Expert Rev Proteomics"},{"key":"key20180107185829_b34-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv Cancer Res"},{"key":"key20180107185829_b35-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/molehr\/gag082","article-title":"Clinical implications of coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine leiomyoma","volume":"9","author":"Sun","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"key20180107185829_b36-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1073\/pnas.0909292106","article-title":"A genomic screen identifies TYRO3 as a MITF regulator in melanoma","volume":"106","author":"Zhu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185829_b37-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0167-4889(98)00144-X","article-title":"Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)","volume":"1448","author":"Kerkhoff","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"key20180107185829_b38-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0560.2009.01317.x","article-title":"Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis","volume":"37","author":"Thomas","year":"2010","journal-title":"J Cutan Pathol"},{"key":"key20180107185829_b39-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ajcp\/90.5.575","article-title":"Juvenile chronic myeloid leukemia. A malignancy of S-100 protein-positive histiocytes","volume":"90","author":"Ng","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"key20180107185829_b40-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2012.246","article-title":"MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1","volume":"32","author":"G\u00f3mez-Casares","year":"2013","journal-title":"Oncogene"},{"key":"key20180107185829_b41-ijo-49-03-0913","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1074\/jbc.M409503200","article-title":"Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway","volume":"280","author":"Vaqu\u00e9","year":"2005","journal-title":"J Biol Chem"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3618\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T20:37:02Z","timestamp":1656794222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,7]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/ijo.2016.3618"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3618","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}